These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

582 related items for PubMed ID: 25637857

  • 1. Effects of Urine Matrix and pH on the Potency of Delafloxacin and Ciprofloxacin against Urogenic Escherichia coli and Klebsiella pneumoniae.
    So W, Crandon JL, Nicolau DP.
    J Urol; 2015 Aug; 194(2):563-70. PubMed ID: 25637857
    [Abstract] [Full Text] [Related]

  • 2. Comparison of the minimum inhibitory, mutant prevention and minimum bactericidal concentrations of ciprofloxacin, levofloxacin and garenoxacin against enteric Gram-negative urinary tract infection pathogens.
    Hansen GT, Blondeau JM.
    J Chemother; 2005 Oct; 17(5):484-92. PubMed ID: 16323436
    [Abstract] [Full Text] [Related]

  • 3. Asymptomatic bacteriuria and symptomatic urinary tract infections (UTI) in patients with diabetes mellitus in Tikur Anbessa Specialized University Hospital, Addis Ababa, Ethiopia.
    Yeshitela B, Gebre-Selassie S, Feleke Y.
    Ethiop Med J; 2012 Jul; 50(3):239-49. PubMed ID: 23409407
    [Abstract] [Full Text] [Related]

  • 4. Antimicrobial susceptibilities of urinary extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae to fosfomycin and nitrofurantoin in a teaching hospital in Taiwan.
    Liu HY, Lin HC, Lin YC, Yu SH, Wu WH, Lee YJ.
    J Microbiol Immunol Infect; 2011 Oct; 44(5):364-8. PubMed ID: 21524974
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Characterization of ESBL-producing Escherichia coli and Klebsiella pneumoniae strains isolated from urine of nonhospitalized patients in the Zagreb region].
    Marijan T, Plecko V, Vranes J, Dzepina AM, Bedenić B, Kalenić S.
    Med Glas (Zenica); 2010 Feb; 7(1):46-53. PubMed ID: 20387724
    [Abstract] [Full Text] [Related]

  • 7. Evaluation of risk factors for colistin resistance among uropathogenic isolates of Escherichia coli and Klebsiella pneumoniae: a case-control study.
    Kaza P, Mahindroo J, Veeraraghavan B, Mavuduru RS, Mohan B, Taneja N.
    J Med Microbiol; 2019 Jun; 68(6):837-847. PubMed ID: 31084700
    [Abstract] [Full Text] [Related]

  • 8. Risk factors of ciprofloxacin resistance in urinary Escherichia coli isolates.
    Lin CY, Huang SH, Chen TC, Lu PL, Lin WR, Chen YH.
    J Microbiol Immunol Infect; 2008 Aug; 41(4):325-31. PubMed ID: 18787740
    [Abstract] [Full Text] [Related]

  • 9. Extended spectrum beta-lactamase producing Escherichia coli and Klebsiella pneumoniae isolated in a rural hospital.
    Basak S, Mallick SK, Bose S.
    J Indian Med Assoc; 2009 Dec; 107(12):855-8. PubMed ID: 20509468
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Fluoroquinolone resistance mechanisms in urinary tract pathogenic Escherichia coli isolated during rapidly increasing fluoroquinolone consumption in a low-use country.
    Christiansen N, Nielsen L, Jakobsen L, Stegger M, Hansen LH, Frimodt-Møller N.
    Microb Drug Resist; 2011 Sep; 17(3):395-406. PubMed ID: 21668371
    [Abstract] [Full Text] [Related]

  • 15. Pharmacodynamic Evaluation of Fosfomycin against Escherichia coli and Klebsiella spp. from Urinary Tract Infections and the Influence of pH on Fosfomycin Activities.
    Fedrigo NH, Mazucheli J, Albiero J, Shinohara DR, Lodi FG, Machado ACDS, Sy SKB, Tognim MCB.
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28607025
    [Abstract] [Full Text] [Related]

  • 16. In vitro potency of amikacin and comparators against E. coli, K. pneumoniae and P. aeruginosa respiratory and blood isolates.
    Sutherland CA, Verastegui JE, Nicolau DP.
    Ann Clin Microbiol Antimicrob; 2016 Jun 17; 15(1):39. PubMed ID: 27316973
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. In vitro activity of fosfomycin and other antimicrobials against uropathogenic Escherichia coli and Klebsiella pneumoniae at a tertiary care center in Lebanon.
    Araj GF, Jaber FA.
    J Med Liban; 2012 Jun 17; 60(3):142-7. PubMed ID: 23198454
    [Abstract] [Full Text] [Related]

  • 19. Comparison of minimum inhibitory concentration values for fluoroquinolones against Escherichia coli causing urinary tract infection in both hospitalized patients and outpatients.
    Tayfour M, Yuce A, Yulug N.
    Saudi Med J; 2001 Oct 17; 22(10):848-51. PubMed ID: 11744939
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.